Operating Expenses Summary of Medifast, Inc.

Medifast, Inc.'s latest annual operating expenses in 2023 was 649.44 Million USD , down -32.04% from previous year.
Medifast, Inc.'s latest quarterly operating expenses in 2024 Q1 was 119.35 Million USD , down -10.05% from previous quarter.
Medifast, Inc. reported a annual operating expenses of 955.6 Million USD in annual operating expenses 2022, up 4.86% from previous year.
Medifast, Inc. reported a annual operating expenses of 911.35 Million USD in annual operating expenses 2021, up 61.69% from previous year.
Medifast, Inc. reported a quarterly operating expenses of 131.31 Million USD for 2024 Q2, up 10.02% from previous quarter.
Medifast, Inc. reported a quarterly operating expenses of 119.35 Million USD for 2024 Q1, down -10.05% from previous quarter.

Annual Operating Expenses Chart of Medifast, Inc. (2023 - 1996)

Historical Annual Operating Expenses of Medifast, Inc. (2023 - 1996)

Year	Operating Expenses	Operating Expenses Growth
2023	649.44 Million USD	-32.04%
2022	955.6 Million USD	4.86%
2021	911.35 Million USD	61.69%
2020	563.65 Million USD	26.43%
2019	445.81 Million USD	43.43%
2018	310.83 Million USD	65.18%
2017	188.18 Million USD	5.24%
2016	178.8 Million USD	3.58%
2015	172.63 Million USD	-3.54%
2014	178.96 Million USD	-23.6%
2013	234.25 Million USD	-4.3%
2012	244.77 Million USD	24.18%
2011	197.11 Million USD	122461.23%
2010	160.82 Thousand USD	-99.85%
2009	105.95 Million USD	47.34%
2008	71.91 Million USD	27.06%
2007	56.6 Million USD	18.57%
2006	47.73 Million USD	84.36%
2005	25.89 Million USD	47.21%
2004	17.59 Million USD	17.61%
2003	14.95 Million USD	116.57%
2002	6.9 Million USD	234.27%
2001	2.06 Million USD	22.32%
2000	1.68 Million USD	-61.71%
1999	4.41 Million USD	-32.91%
1998	6.57 Million USD	-16.02%
1997	7.82 Million USD	14.41%
1996	6.84 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q3	103.56 Million USD	-21.13%
2024 Q2	131.31 Million USD	10.02%
2024 Q1	119.35 Million USD	-10.05%
2023 Q3	151.86 Million USD	-11.71%
2023 Q4	132.69 Million USD	-12.63%
2023 FY	649.44 Million USD	-32.04%
2023 Q1	192.87 Million USD	-4.04%
2023 Q2	172 Million USD	-10.82%
2022 Q3	234.69 Million USD	-13.94%
2022 Q4	200.99 Million USD	-14.36%
2022 FY	955.6 Million USD	4.86%
2022 Q1	247.19 Million USD	6.8%
2022 Q2	272.71 Million USD	10.32%
2021 Q1	195.74 Million USD	21.38%
2021 Q4	231.44 Million USD	-8.11%
2021 Q2	232.27 Million USD	18.66%
2021 FY	911.35 Million USD	61.69%
2021 Q3	251.88 Million USD	8.44%
2020 FY	563.65 Million USD	26.43%
2020 Q4	161.27 Million USD	1.12%
2020 Q2	131.2 Million USD	17.45%
2020 Q1	111.7 Million USD	2.15%
2020 Q3	159.47 Million USD	21.55%
2019 FY	445.81 Million USD	43.43%
2019 Q4	109.36 Million USD	-10.85%
2019 Q3	122.67 Million USD	8.22%
2019 Q2	113.35 Million USD	12.87%
2019 Q1	100.43 Million USD	12.48%
2018 FY	310.83 Million USD	65.18%
2018 Q1	60.12 Million USD	21.12%
2018 Q2	71.68 Million USD	19.23%
2018 Q3	89.73 Million USD	25.17%
2018 Q4	89.28 Million USD	-0.5%
2017 Q3	47.95 Million USD	3.57%
2017 Q1	44.28 Million USD	9.43%
2017 Q2	46.3 Million USD	4.56%
2017 FY	188.18 Million USD	5.24%
2017 Q4	49.64 Million USD	3.51%
2016 Q2	48.2 Million USD	2.72%
2016 Q3	43.21 Million USD	-10.35%
2016 Q4	40.46 Million USD	-6.35%
2016 FY	178.8 Million USD	3.58%
2016 Q1	46.92 Million USD	18.25%
2015 FY	172.63 Million USD	-3.54%
2015 Q2	44.5 Million USD	-5.83%
2015 Q1	47.25 Million USD	15.86%
2015 Q4	39.68 Million USD	-3.64%
2015 Q3	41.18 Million USD	-7.46%
2014 Q2	52.94 Million USD	-4.15%
2014 Q4	40.79 Million USD	-16.72%
2014 Q1	55.23 Million USD	9.1%
2014 Q3	48.97 Million USD	-7.5%
2014 FY	178.96 Million USD	-23.6%
2013 FY	234.25 Million USD	-4.3%
2013 Q4	50.63 Million USD	-11.95%
2013 Q3	57.5 Million USD	-7.68%
2013 Q2	62.28 Million USD	-2.42%
2013 Q1	63.83 Million USD	7.81%
2012 Q4	59.2 Million USD	-0.34%
2012 Q1	60.61 Million USD	19.66%
2012 Q2	65.54 Million USD	8.12%
2012 Q3	59.4 Million USD	-9.36%
2012 FY	244.77 Million USD	24.18%
2011 Q4	50.65 Million USD	1.78%
2011 Q3	49.77 Million USD	-0.57%
2011 Q2	50.05 Million USD	7.34%
2011 Q1	46.63 Million USD	11.98%
2011 FY	197.11 Million USD	122461.23%
2010 Q4	41.64 Million USD	0.56%
2010 Q3	41.41 Million USD	2.99%
2010 Q2	40.21 Million USD	7.04%
2010 Q1	37.56 Million USD	27.33%
2010 FY	160.82 Thousand USD	-99.85%
2009 Q1	21.61 Million USD	19.43%
2009 Q2	26.17 Million USD	21.12%
2009 Q3	28.67 Million USD	9.54%
2009 Q4	29.5 Million USD	2.9%
2009 FY	105.95 Million USD	47.34%
2008 Q3	18.36 Million USD	-0.48%
2008 FY	71.91 Million USD	27.06%
2008 Q1	17 Million USD	26.13%
2008 Q4	18.09 Million USD	-1.46%
2008 Q2	18.45 Million USD	8.49%
2007 Q2	15.23 Million USD	19.08%
2007 Q3	14.76 Million USD	-3.07%
2007 FY	56.6 Million USD	18.57%
2007 Q4	13.48 Million USD	-8.68%
2007 Q1	12.79 Million USD	-61.01%
2006 Q3	12.96 Million USD	3.24%
2006 FY	47.73 Million USD	84.36%
2006 Q4	32.8 Million USD	153.0%
2006 Q2	12.56 Million USD	10.65%
2006 Q1	11.35 Million USD	68.64%
2005 Q3	7.04 Million USD	3.92%
2005 Q4	6.73 Million USD	-4.44%
2005 FY	25.89 Million USD	47.21%
2005 Q1	5.34 Million USD	42.12%
2005 Q2	6.77 Million USD	26.91%
2004 Q4	3.75 Million USD	-22.6%
2004 Q1	4.54 Million USD	20.67%
2004 Q2	4.42 Million USD	-2.62%
2004 Q3	4.85 Million USD	9.62%
2004 FY	17.59 Million USD	17.61%
2003 Q3	4.14 Million USD	8.67%
2003 Q4	3.76 Million USD	-9.16%
2003 FY	14.95 Million USD	116.57%
2003 Q1	3.22 Million USD	-5.13%
2003 Q2	3.81 Million USD	18.57%
2002 Q2	1.37 Million USD	69.91%
2002 Q4	3.39 Million USD	156.54%
2002 Q3	1.32 Million USD	-3.99%
2002 Q1	811 Thousand USD	59.65%
2002 FY	6.9 Million USD	234.27%
2001 Q4	508 Thousand USD	-18.59%
2001 FY	2.06 Million USD	22.32%
2001 Q3	624 Thousand USD	24.3%
2001 Q1	432 Thousand USD	121.09%
2001 Q2	502 Thousand USD	16.2%
2000 FY	1.68 Million USD	-61.71%
2000 Q4	195.39 Thousand USD	-63.03%
2000 Q1	406 Thousand USD	35.33%
2000 Q3	528.52 Thousand USD	-5.46%
2000 Q2	559.07 Thousand USD	37.7%
1999 Q3	1.8 Million USD	12.5%
1999 Q4	300 Thousand USD	-83.33%
1999 Q2	1.6 Million USD	57.95%
1999 Q1	1.01 Million USD	-7.91%
1999 FY	4.41 Million USD	-32.91%
1998 Q4	1.1 Million USD	-8.33%
1998 FY	6.57 Million USD	-16.02%
1998 Q1	1.7 Million USD	-29.17%
1998 Q3	1.2 Million USD	500.0%
1998 Q2	-300 Thousand USD	-117.65%
1997 Q2	2 Million USD	11.11%
1997 Q1	1.8 Million USD	20.0%
1997 FY	7.82 Million USD	14.41%
1997 Q4	2.4 Million USD	41.18%
1997 Q3	1.69 Million USD	-15.0%
1996 Q3	1.69 Million USD	0.0%
1996 Q4	1.5 Million USD	-11.76%
1996 FY	6.84 Million USD	0.0%

Peer Operating Expenses Comparison of Medifast, Inc.

Name	Operating Expenses	Operating Expenses Difference
H&R Block, Inc.	813.5 Million USD	20.167%

Global Stocks Search

Medifast, Inc. (0K05.L)

Operating Expenses Summary of Medifast, Inc.

Annual Operating Expenses Chart of Medifast, Inc. (2023 - 1996)

Historical Annual Operating Expenses of Medifast, Inc. (2023 - 1996)

Peer Operating Expenses Comparison of Medifast, Inc.